David Einhorn’s hedge fund Greenlight Capital picked up a new stake in Kenvue Inc. KVUE,…
Johnson & Johnson
-
-
A record number of people in the U.S. will turn 65 this year. Here’s how…
-
STOCK MARKET
Kenvue’s stock slides 5.8% as J&J spinoff’s revenue and guidance fall short of expectations
by userby userKenvue Inc.’s stock fell 5.8% at the closing bell on Thursday, after the consumer-health business…
-
STOCK MARKET
J&J, Merck and Bristol Myers CEOs, under fire on Capitol Hill, seek to turn up heat on drug-market middlemen
by userby userDrugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to deflect…
-
STOCK MARKET
Johnson & Johnson’s earnings beat estimates with boost from medical-technology sales
by userby userJohnson & Johnson posted stronger-than-expected earnings for the fourth quarter early Tuesday and offered guidance…
-
STOCK MARKET
Kenvue’s stock rises after favorable court ruling in Tylenol litigation
by userby userShares of Kenvue Inc. KVUE, +4.02% gained nearly 5% Tuesday morning after a federal court’s…
-
STOCK MARKET
Why a derailed $11 trillion corporate bond market looks ripe for a comeback as U.S. inflation slows
by userby userSlowing U.S. inflation has sparked hopes of a big turnaround for hard-hit parts of the…
-
STOCK MARKET
Johnson & Johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech business
by userby userJohnson & Johnson on Tuesday posted better-than-expected third-quarter earnings and raised its profit guidance while…
-
While the current deal landscape on Wall Street remains low on M&A, initial public offerings…
-
STOCK MARKET
Medicare drug price negotiations move forward with all drugmakers participating, White House says
by userby userAll of the primary manufacturers of the 10 drugs selected in August for Medicare price…